molnupiravir: Big news! Corolla’s antiviral pill Molnupiravir launches in India, price is …

New Delhi : Covid antiviral drug pill Molnupiravir launched in India (molnupiravir launched in india). Patients with mild to moderate coronary heart disease had to take a five-day course of the pill. Patients will have to pay Rs 1,399 for this 5 day course.

An expert panel of the Central Drug Standards Control Organization (CDSCO) has recently approved the antiviral drug Molnupiravir for emergency use against the backdrop of increasing number of patients with a new variant of Corona Omicron in the country. Along with Molnupiraveer, CDSCO had also approved Serum Institute of India’s Covid vaccine COVOVAX and Hyderabad’s biological E RBD protein CORBEVAX vaccine for emergency use.

Molanupiravir is an antiviral drug, which restricts specific RNA viruses. This drug is used to treat COVID-19 in those infected with SARS-CoV-2. The recommended dose of Molnupiravir 800 mg is five days and should be taken twice a day. The patient needs to take 40 tablets (capsules) of 200 mg each. Toronto, Cipla, Sun Pharma, Dr. Many pharma companies like Reddy’s, Natco, Mylan and Hetero are in the process.

India Lockdown Update: Should Lockdown be imposed in the country? The head of the Covid Task Force answered ‘yes’

Cipla, Sun Pharma and Dr Reddy’s Laboratories are also expected to launch Molnupiravir capsules in the coming weeks.

omicron: Omicron patients are recovering in a week, why are doctors still warning? Find out …

The Molnupiravir pill, developed by MSD and Ridgeback Biotherapeutics, has been approved by the UK’s drug regulator. It is the first anti-covid pill to be taken orally. The US Food and Drug Administration (USFDA) has approved Molnupiravir for the treatment of mild to moderate covid-19 in adults and those at high risk of serious illness.